Blueprint Patient-Specific Instrumentation; Shoulder iD Primary Reversed Glenoid— 510(k) K241491

Name: FDA 510(k) clearance K241491
Creator: U.S. Food and Drug Administration
Published: 2024-10-10

Substantially Equivalent

Stryker Corporation (Tornier, S.A.S.)

FDA 510(k) clearance K241491 for Blueprint Patient-Specific Instrumentation; Shoulder iD Primary Reversed Glenoid, Substantially Equivalent on 2024-10-10. Applicant: Stryker Corporation (Tornier, S.A.S.). Device class: 2.

Clearance details

Applicant: Stryker Corporation (Tornier, S.A.S.)
Product code: Code PHX
Device class: Class 2
Regulation: 21 CFR 888.3660
Advisory panel: Orthopedic
Date received: 2024-05-24
Decision date: 2024-10-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montbonnot-Saint-Martin, FR

Download summary PDF View on FDA.gov ↗

Recent devices under product code PHX

view all

K260556 — Veritas Shoulder System2026-07-01
K261683 — Augment Off-Axis Instrument System2026-06-16
K260102 — Tornier Perform Reversed Glenoid and Tornier Perform Reversed Augmented Glenoid Shoulder System2026-06-12
K261016 — MSS - Humeral reverse liners extension2026-06-10
K253992 — Veritas Reverse Total Shoulder System2026-05-07

More clearances from Stryker Corporation (Tornier, S.A.S.)

view all

K253674 — Blueprint Patient-Specific Instrumentation2026-04-03

Adverse events under product code PHX

product code PHX

Death: 10
Injury: 9,705
Malfunction: 1,252
Total: 10,967

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.